Searched for
EMCURE PHARMA SHARES
Stocks in news: Emcure Pharma, Dixon Technologies, Ajanta Pharma, Godrej Properties, VedantaIndian markets experienced a volatile session, closing higher amidst mixed signals. Bulls are defending the 23,000 level in Nifty, but unce...- PE investor BC Investments sells Rs 612 crore stake in Emcure Pharma; Kotak MF picks up stakePrivate equity firm BC Investments IV sold a Rs 612 crore stake in Emcure Pharmaceuticals to Kotak Mahindra Mutual Fund at Rs 1,700 per sha...
- Stocks in news: Paytm, Bajaj Auto, L&T, Bharti Airtel, Hero MotoCorpMarkets closed lower amid global headwinds and geopolitical worries. Several companies like Paytm, Bajaj Auto, and L&T are in focus due to ...
- Adani Ports, Tata Motors and Siemens Energy witness block deal action on MondayInstitutional investors injected over Rs 7,400 crore into Adani Ports and Special Economic Zone (APSEZ) on Monday through significant block...
- Mauritius-based entity sells Rs 289 crore worth shares in Emcure Pharmaceuticals via block deal; Norges Bank acquirerEmcure Pharmaceuticals saw a significant block deal where BC Investments IV Limited sold 18 lakh shares for Rs 289 crore to Norges Bank. Th...
- Two Trades for Today: 2 pharma companies, one a large-cap for a 6.65% upmove, the other a mid-cap for a gain of about 5%Our technical analysts identify select stocks that may gain momentum even in volatile markets. Here are the technical calls for today.
- Emcure Pharma shares in focus after GST Department conducts search at Mumbai officesEmcure Pharmaceuticals' shares could see action following a Goods and Services Tax search at its Mumbai offices. The inspection concluded t...
- Emcure Pharma Q2 profit rises 25%, revenue up 13% on broad-based growthPune-based Emcure Pharmaceuticals reported a 13.4% year-on-year rise in consolidated revenue to ₹2,270 crore in the September quarter, supp...
- Stocks in news: TCS, Akzo Nobel, Indosolar, Emcure Pharma, Enviro InfraMarkets experienced volatility within a tight range, closing slightly lower, continuing the consolidation trend. TCS is set to release its ...
- Emcure Pharma shares in focus as Bain Capital likely to offload 2.4% stake via block dealBC Investments IV, linked to Bain Capital, is expected to sell a 2.4% stake in Emcure Pharmaceuticals. The sale will occur through a block ...
- Emcure Pharma shares advance 10% as Kotak Equities sees 28% upside in stockDriven by strong organic growth, an in-licensing agreement with Sanofi, the consolidation of Mantra, and the resolution of most legal chall...
- Emcure Pharma shares jump over 4% post listing. Should you buy, sell or hold?Pune-based Emcure Pharmaceuticals listed at Rs 1,325, a 31.4% premium on Rs 1,008 IPO price. QIBs subscribed 195.8 times, non-institutional...
- Emcure Pharma shares debut with 31% premium over issue priceBefore listing, the company's shares traded at a Rs 360 premium in the grey market. It raised Rs 582 crore from anchor investors, including...
- Emcure Pharma IPO GMP: Street anticipates a robust listing tomorrow. Will it trump expectations?Emcure Pharmaceuticals' shares to debut on stock exchanges with a GMP of Rs 360. Analysts bullish on both short-term and long-term gains. C...
- Emcure Pharmaceuticals IPO fully subscribed on Day 1. Check GMP and other detailsEmcure Pharmaceuticals' IPO attracts high demand from investors, with a price range of Rs 960-1008 per share. Analysts foresee business imp...
- IPO Analysis: Emcure has better-listed pharma alternativesEmcure Pharma, with its strong presence in gynaecology and HIV therapeutic areas, secured significant investments from anchor investors lik...
- Emcure Pharma to launch IPO in 3 months: Namita Thapar of Shark Tank fameShark Tank fame and Executive Director of Emcure Pharmaceuticals, Namita Thapar said at the ET NOW Global Business Summit 2024 on February ...
- Generics company Emcure plans Rs 4,000 crore IPOEmcure may appoint as many as six bankers for the IPO including JM Financial, Kotak Capital, Axis Capital and SBI Capital, the people said....
- Pharma stocks soar despite US lawsuitAmong other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.
- USFDA issues import alert against Emcure Pharma's Pune plantUS health regulator has issued an import alert against Pune-based Emcure Pharmaceuticals for products made at its plant in Hinjwadi, Pune.
Load More
